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Moving pictures of the human microbiome
J Gregory Caporaso1, Christian L Lauber2, Elizabeth K Costello3, Donna Berg-Lyons2, Antonio Gonzalez4,
Jesse Stombaugh1, Dan Knights4, Pawel Gajer5, Jacques Ravel5, Noah Fierer2,6, Jeffrey I Gordon7 and Rob Knight1,8*

Abstract
Background: Understanding the normal temporal variation in the human microbiome is critical to developing
treatments for putative microbiome-related afflictions such as obesity, Crohn’s disease, inflammatory bowel disease
and malnutrition. Sequencing and computational technologies, however, have been a limiting factor in performing
dense time series analysis of the human microbiome. Here, we present the largest human microbiota time series
analysis to date, covering two individuals at four body sites over 396 timepoints.
Results: We find that despite stable differences between body sites and individuals, there is pronounced variability
in an individual’s microbiota across months, weeks and even days. Additionally, only a small fraction of the total
taxa found within a single body site appear to be present across all time points, suggesting that no core temporal
microbiome exists at high abundance (although some microbes may be present but drop below the detection
threshold). Many more taxa appear to be persistent but non-permanent community members.
Conclusions: DNA sequencing and computational advances described here provide the ability to go beyond
infrequent snapshots of our human-associated microbial ecology to high-resolution assessments of temporal
variations over protracted periods, within and between body habitats and individuals. This capacity will allow us to
define normal variation and pathologic states, and assess responses to therapeutic interventions.

Background
As more attention is paid to viewing ourselves as a
supraorganism, comprising interacting microbial and
human cellular and genetic components, it is apparent
that much more precise understanding is needed of
what constitutes normal temporal variations in our
microbial community structures and functions. Variation
in the human microbiome within and between our various body habitats, lifecycle stages, and cultural settings
is largely unexplored. High-resolution time series studies
provide a foundation for discriminating between ‘normal’ perturbations and pathologic states, and between
organisms that are simply passing through a body habitat or are entrenched residents of an ecosystem. Similarly, these types of studies are needed to understand
the immigration and emigration patterns of microbes
between our body sites, between cohabitating individuals, and between ourselves and the myriad of environments we contact on a daily basis [1-3].
* Correspondence: rob.knight@colorado.edu
1
Department of Chemistry and Biochemistry, University of Colorado, 215
UCB, Boulder, CO 80309, USA
Full list of author information is available at the end of the article

The densest human microbiome time series reported
to date studied the response of distal gut microbial communities to the antibiotic ciprofloxacin across three
individuals, with sampling intervals varied from daily to
weekly. Eighteen timepoints were collected per individual in an initial study [4], and between 52 and 56 timepoints were collected per subject in a follow-up study
[5]. In both studies, rapid decreases in alpha diversity
and a characteristic shift in community composition
were observed in association with antibiotic therapy, followed by a rapid post-antibiotic increase in diversity as
the gut community returned to a state similar (but not
identical) to the pre-treatment state. Another dense
human microbiome time series studied 60 fecal samples
over the first 2.5 years of life for a single infant, and illustrated the successional pattern in the human gut
microbiota as a rapidly changing community that develops over time into a community characteristic of that
found in the adult human gut [2].
The availability of radically cheaper sequencing and
analysis, described here, eases constraints on the number of timepoints and body sites that can be compared
in a single study, and paves the way to a finer-grained
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understanding of how the human microbiota changes in
different body habitats (including much better estimates
of the relative variability of different body sites within a
subject). Understanding this intrinsic variability will be
crucial for performing power calculations to test
whether antibiotics, probiotics, or other drugs actually
affect the microbiome.
In this study, two healthy subjects, one male (M3) and
one female (F4), one of whom (M3) participated in an
earlier survey [6], were sampled daily at three body sites
(gut (feces), mouth, and skin (left and right palms)), for
15 months (M3) and for 6 months (F4) using an institutional review board-approved protocol. Variable region
4 (V4) of 16S rRNA genes present in each community
sample were amplified by PCR and subjected to multiplex sequencing on an Illumina Genome Analyzer IIx
(GA-IIx; average read length after quality trimming, 123
± 17 (standard deviation (SD)) nucleotides; 32,266 ±
19,723 (SD) reads per sample; n = 1,422 (M3 samples);
n = 531 (F4 samples); average interval between sampling, 1.12 days). To control for differences across
sequencing platforms and primer pairs, 331 of these
samples had variable region 2 (V2) sequenced on 454
(average read length after quality filtering, 228 ± 11
(SD) nucleotides; 1,072 ± 375 (SD) reads per sample;
n = 171 (M3 samples); n = 160 (F4 samples)). This
study thus provides a key counterpoint to recent studies
of one or a few subjects at tens of timepoints [2-5,7], or
studies that examine hundreds of individuals but only at
one or a few timepoints [6,8-12].

Results and discussion
Stable differences in microbial communities between
body sites over time

When the samples from Costello et al. [6] and the current study are compared directly, the samples cluster by
body habitat, showing excellent concordance between
the studies (Figure 1a in [6]; Figure 1b in the current
study) despite differences in sequencing technology (454
and Illumina GA-IIx, respectively), mean read length
(229 ± 16 (SD) nucleotides and 123 ± 17 (SD) nucleotides, respectively), and region of the 16S sequenced (V2
and V4, respectively). The UniFrac distances between
the 331 time series samples that were sequenced on
both Illumina and 454 were significantly correlated, as
determined by Procrustes analysis of unweighted UniFrac principal coordinate matrices (M2 = 0.161; Monte
Carlo P < 0.001; Additional file 1) and Pearson correlation of UniFrac distances for pairs of samples (r = 0.91;
P < 0.001). As observed by Costello et al. [6], gut, oral,
and skin bacterial communities were found to be compositionally distinct based on principal coordinates analysis of unweighted UniFrac distances between
communities (UniFrac measures community similarity
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Figure 1 Principal coordinates analysis of unweighted UniFrac
distances between samples. (a) Costello et al. [6] samples. (b) M3,
F4 time series samples. (c) M3, F4 time series, PC1 versus time
(days). Panels (a,b) and (c) show two independent principal
coordinates analyses. To compare the Costello et al. 454 data (a)
with the time series Illumina data (b), these data were generated in
a single principal coordinates analysis of UniFrac distances at 500
sequences per sample. Panel (c) does not contain the 454 data, so
makes use of the increased sampling depth possible on Illumina
(evenly sampled to 5,000 sequences per sample for UniFrac
calculations).

based on the degree to which they share branch length
on a phylogenetic tree). The long-term time series
shows for the first time that this body-site differentiation
is highly stable over greater than one year (Figure 1c),
but dynamic within sites over time (Additional files 2, 3,
4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15).
Minimal evidence for a temporal core microbiome
between or within body sites

While overall compositional differences between body
sites and individuals were relatively stable, our data also
suggest a surprisingly small temporal ‘core human
microbiota’ within an individual’s body sites (Figure 2)
when we define the ‘core’ as those species-level phylotypes in a given body habitat that were observed across
all sampling events. These data suggest a minimal core
microbiome across time, where the size of the core
decreases as: mouth > gut > right palm ≈ left palm >
across body sites within an individual > across body
sites and individuals.
At this depth of sequencing, many more OTUs are
either persistent community members, which appear in
a given body habitat and remain for an extended period
of time but are not present consistently enough to be
considered core members, or transient community
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Number of OTUs in core

members, which appear in a body habitat and disappear
soon after (Figure 3). The taxa composing these persistent and transient categories are significantly different
(for example, M3 gut: Gindep, 84.78; P = 1.80 × 10-14). In
M3 gut, both the persistent and transient communities
are dominated by Clostridia, Bacteroidia, and to a lesser
extent Erysipelotrichi. The persistent community is,
however, also composed of Betaproteobacteria and Deltaproteobacteria, while the transient community is composed of Actinobacteria, Gammaproteobacteria,
Epsilonproteobacteria, and Verrucomicrobiae. Taxonomic summaries of the persistent and transient groups
for all body sites from both individuals are presented in
Additional file 16.
We applied several techniques to control for the possibility of persistent groups being mistaken for transient
groups if they occasionally fell below the detection
threshold. First, in computing the maximum number of
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Figure 2 Temporal core microbiome. Fraction of species-level
operational taxonomic units (OTUs) composing the core microbiota
by number of samples in which an OTU must be present to be
considered part of the core.
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Figure 3 Community membership. Community membership summary for all OTUs in (a) M3 gut, (b) F4 gut, (c) M3 tongue, (d) F4 tongue, (e)
M3 left palm, (f) F4 left palm, (g) M3 right palm, and (h) F4 right palm. Points are OTUs colored by their median relative abundance computed
over all samples where they occur, and pie charts summarize the class-level taxa observed as persistent and transient OTUs.
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consecutive observations for an OTU, we counted a single zero-count for an OTU as not interrupting a run of
consecutive observations, provided that both adjacent
timepoints achieved non-zero counts for that OTU. Second, we re-sequenced 331 of the time series samples on
the 454 platform, and recomputed the persistent and
transient taxa summaries. We found that, for both individuals, the composition of the persistent gut and oral
communities were not significantly different between
454 and Illumina despite a nearly 40-fold difference in
sequencing depth. However, the persistent palm communities were significantly different in both cases. A
possible confounding factor in this comparison is primer
bias, as the V2 region was sequenced on 454. We therefore performed 1,000 jackknife iterations of this analysis
by subsampling the Illumina data to 5,000 sequences
per sample and recomputing the composition of the
persistent group for each individual and body habitat. In
this analysis, seven of the eight individual/body site
pairs were never significantly different from the persistent community composition on the full Illumina data
set. The one exception was the F4 gut community,
which was significantly different in approximately half of
the iterations. When re-sampled at a depth of 10,000
sequences per sample, the persistent F4 gut community
never achieved significant difference from that determined on the full Illumina data set. The full results of
these analyses are presented in Additional file 17. The
designation of groups as ‘persistent’ was thus highly
reproducible across sequencing platforms and amplicons, although it is still possible that sequencing error
or very low abundance taxa occasionally falling below
the detection threshold could result in underestimated
size of the persistent group.
Temporally dynamic microbial communities and
correlations between body sites

Differences in UniFrac distances in the left and right
palms in adjacent timepoints of both individuals were
significantly correlated (Pearson correlation for M3, r =
0.69, P = 2.07 × 10-46; for F4, r = 0.64, P = 3.77 × 1016
), possibly due to equilibration of microbial communities across palms by physical contact. We did not see
correlations between other body sites. While the magnitude and direction of change in phylogenetic dissimilarity between adjacent timepoints were correlated between
the palm sites, the species-level microbial taxa present
on each hand were not significantly correlated, confirming previous observations that, at a single timepoint, the
left and right hand of a single individual may share relatively few OTUs [13].
For single body sites, within-subject distances were
lower than between-subject distances, suggesting a
stable pattern, consistent across body sites, in between-
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subject dissimilarities across time. For example, the
between-subject fecal sample distances were significantly
higher than the within M3 fecal sample distances (t =
15.52; P < 0.001; one-tailed, two sample t-test) and the
within F4 fecal sample distances (t = 33.45; P ≤ 0.001;
one-tailed, two sample t-test).
The microbial community dynamics are especially
apparent in principal coordinates analysis animations
(Additional files 2, 3, 4, 5, 6, 7) where the sample types
(subject, body site combinations) are represented as
moving traces against a background of the Costello et
al. data. The traces give an immediate picture of the
variability within each body site, the relative distinctiveness of the sites and the subjects, and the relative speed
of change in each site. Blooms of certain taxa contribute
to the within site dissimilarities over time, as with the
waning and waxing of the relative Proteobacteria abundance in the gut of both M3 and F4 (Additional files 8
and 9, Phylum panel (teal)). Similar patterns are apparent across all taxonomic levels and body sites (Additional files 8, 9, 10, 11, 12, 13, 14, 15). Such
visualizations of microbial community dynamics will add
another dimension to long-term studies of variable clinical states, such as inflammatory bowel disease or drug
treatments, and changes in diet or lifestyle.

Conclusions
Dense, deeply sequenced microbiome time series studies
have been limited by the cost of sequencing, and the
computational power necessary to analyze such studies
has been expensive. Several technical advances made
this study possible. First, using the Illumina sequencer
and the protocol described in [14] reduced sequencing
cost per sample ($11 USD) to below the cost associated
with DNA extraction and PCR ($13). Second, cloud
computing using Amazon Web Services (AWS) allowed
us to perform the bioinformatics analysis for $200 using
open-source and freely available software running on
commodity services. This included the creation of a virtual cluster on AWS composed of 20 eight-core systems
with 68 GB of RAM each (that is, 20 Amazon
m2.4xlarge instances) to cluster approximately 69 million sequences into OTUs. This step alone would have
required 20 days of computation on a desktop machine
with 8 GB of RAM, but was performed on this virtual
cluster in 3 hours for $120.
Figure 2 illustrates the sensitivity of conclusions about
the core microbiome to the definition of the core microbiome: if an OTU is considered here to be a core member only if it is present in all 130 samples, as compared
to 120 of the samples, the size of the core drops to
approximately 5% of OTUs from about 10% of OTUs.
This rapid change in slope beyond 120 samples on the
x-axis does not occur when considering all M3 gut or
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oral samples rather than only 130 (data not shown), suggesting that this result likely stems from a few nonrepresentative samples, rather than representing an
interesting biological result. The definition of the core
microbiome is thus a crucial consideration, because
depth of sampling, PCR error, sequencing error, analysis
techniques (such as OTU picking method and similarity
threshold), among other factors, will affect whether an
OTU will be observed in a given sample. OTU picking
similarity threshold, in particular, will have a large affect
on the size of the observed core microbiome. As this
threshold is decreased, OTUs represent larger taxonomic groups, and the observed core will increase in
size correspondingly. For example, there is clearly a
temporal core at the phylum level in the fecal samples
studied here composed of Bacteriodetes and Firmicutes
(Additional files 8 and 9). For this reason our results do
not necessarily contradict previous Denaturing Gradient
Gel Electrophoresis (DGGE)-based work in this area
[4,15-17], which is suggestive of a core gut microbiome
but at a coarser phylogenetic resolution and more limited dynamic range. Sampling depth will also considerably affect the definition of the core, and although the
dynamic range of this study is large compared to other
studies of human body habitats, it is possible that
microbes we define as ‘non-core’ still persist at very low
abundance, perhaps in a manner analogous to a seed
bank. Determining the role, if any, of these low-abundance microbes in responding to changes in diet, physiological status, and so on will be a fascinating
challenge for future studies.
Taken together, our observations paint a picture of a
human microbiome that is highly variable over time
(Figures 2 and 3; Additional files 2, 3, 4, 5, 6, 7, 8, 9,
10, 11, 12, 13, 14, 15), but from which stable patterns
of similarities and differences among body habitats and
individuals emerge (Figure 1). This temporal variation
may arise from extrinsic factors, such as exposure to
different types of foods, medications, or physical environments (for example, due to travel), or from intrinsic
factors, such as the adaptive immune system. Understanding the influence of these factors on an individual’s microbiota is an additional challenge for future
work.
Although some evidence was found for a high-abundance core microbiome at the 97% OTU level within
body sites over time, particularly in the mouth and gut,
this core appears to represent less than 10% of the total
OTUs when defining the minimum number of samples
to be considered part of the core as 90% of the samples.
This observation does not, however, extend across body
sites, suggesting that a body-wide core temporal microbiome that bridges the habitat types surveyed here does
not exist.
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The innovations in sequencing, cloud computing, and
visualization applied here, together with advances in
robust and inexpensive microfluidic sample preparation
techniques, support the development and democratization of inexpensive, informative, and personalized
microbiome-based phenotyping. Specifically, the ability
to collect, process and analyze thousands of sequences
using increasingly available sequencing technologies and
using commercial computing infrastructure will make
the ability to trace changes in the microbiome within
each individual associated with drug administration, disease states, and environmental exposures routine.
Because of the immense subject-to-subject variability in
the microbiome, studies examining temporal variability,
which give a view of dynamics beyond the static pictures
previously available, have the potential to transform our
understanding of what is ‘normal’ in the human body,
and, perhaps, to develop predictive models for the
effects of clinical interventions.

Materials and methods
Sample preparation and sequencing

Sample collection and DNA isolation were performed as
described in Costello et al. [6]; and PCR, sequencing,
and quality filtering of reads were performed as
described in Caporaso et al. [14]. Samples were not collected on days 422 through 437.
To facilitate massively parallel sequencing (1,967 samples), barcodes were reused across six lanes in a single
Illumina GAIIx, with 374, 372, 364, 271, 265, and 323
samples in lanes 1 through 6, respectively (differing
from Caporaso et al. [14], where samples were pooled
and run over seven lanes). Sixteen samples were ultimately excluded from the analysis as fourteen samples
were identified as potentially mislabeled (discussed
below), and the barcodes for two samples were not
found in the sequencing output, likely indicating a problem with amplification for those two samples.
Data analysis

To directly compare these M3/F4 time series samples
with the samples presented in Costello et al. [6], which
sequenced a different variable region (V2) using a different technology (454 FLX), a reference-based OTU picking protocol [18] was applied. After demultiplexing and
quality filtering sequences, 97% OTUs were picked
against the Greengenes database [19] (pre-filtered at
97% identity) using uclust [20]. Reads were assigned to
OTUs based on their best match to a Greengenes
sequence, and reads that did not match a Greengenes
sequence at 97% or greater sequence identity were discarded. The Greengenes taxonomy associated with the
best match in Greengenes was assigned to each OTU,
and the Greengenes tree was used for phylogenetic
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diversity calculations. These steps and subsequent data
analysis were performed using Quantitative Insights Into
Microbial Ecology (QIIME) on AWS.
Identifying mislabeled samples

To identify potentially mislabeled samples, we used the
random forests classifier [21]. A 2,000-tree forest was
trained on the OTU × Sample Abundance matrix after
evenly sampling to 500 sequences per sample and
removing OTUs present in less than 1% of samples. The
posterior probability that a given sample came from
each of the body habitats (gut, oral cavity, skin) was estimated using only those trees in the forest that did not
contain that sample in their training sets, to avoid overfitting. The classifier considers samples to be mislabeled
when their alleged environment labels have a low posterior probability (<60%). Fourteen such samples were
identified, and these samples were removed from all
analyses.
Core microbiome calculation

The temporal core microbiome across body sites and
individuals (Figure 2) was computed by varying the
minimum number of samples in which an OTU must
be observed to be considered part of the core microbiome, and then determining the number and fraction
of total OTUs observed in each site (or combination of
sites) that are part of the core. To facilitate direct comparison across sample types that contained different
numbers of observations (for example, M3 (all) versus
M3 gut), we randomly subsampled to exactly 130 observations per sample type, corresponding to the sample
type for which we had the fewest observations.
Community membership calculations

The number of consecutive timepoints containing an
OTU (Figure 3) was calculated as the maximum number
of consecutive timepoints where an OTU was observed,
allowing a zero count at a single timepoint to be considered part of a continuous stretch of non-zero counts if
both adjacent timepoints had a non-zero count. This
controls for sampling error as, for example, a long contiguous stretch of non-zero counts for an OTU interrupted by a single zero count for that OTU would likely
indicate a bad sample, rather than a biologically relevant
fact about that OTU in relation to the community. Persistent taxa were defined as those observed in 20% or
more of the timepoints, but with at least 90% of those
observations being consecutive (that is, they appear and
remain present). Transient taxa were defined as those
observed in at least 60% of the samples, but with at
most 75% of those observations being consecutive (that
is, they appear and disappear from the community
frequently).
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Animated microbial community dynamics

Animations were created in inVUE [22] based on the
principal coordinate data presented in Figure 1a, b.
inVUE files can be created in QIIME from the principal
coordinate matrix and associated metadata file. After
installing and opening inVUE, the user can run, pause,
and stop the animations associated with different metadata categories.
Data availability

All sequence data and sample metadata are publicly
available under the ‘Moving Pictures of the Human
Microbiome’ project [MG-RAST:4457768.3-4459735.3].

Additional material
Additional file 1: Comparison of beta diversity results for 331
samples sequenced on both 454 and Illumina. Procrustes plot
comparing principal coordinates of unweighted UniFrac distances. Lines
connect paired samples sequences on 454 (white tip of line) and
Illumina (red tip of line). The Illumina samples were evenly sampled to
5,000 sequences per sample and the 454 samples were evenly sampled
to 500 sequences per sample.
Additional file 2: Animation tracing change in position in PC1 and
PC2 with time for all body sites across both individuals. The view
presented in this video is directly comparable with Figure 1a.
Background colors correspond to Figure 1a. The M3 time series is shown
as a red trace (with left palm in orange), and the F4 time series is shown
as a blue trace (with left palm in white).
Additional file 3: Animation tracing change in position in PC1 and
PC2 with time for all body sites across M3. The view presented in this
video is directly comparable with Figure 1a. Background colors
correspond to Figure 1a. The M3 time series is shown as a red trace
(with left palm in orange).
Additional file 4: Animation tracing change in position in PC1 and
PC2 with time for all body sites across F4. The view presented in this
video is directly comparable with Figure 1a. Background colors
correspond to Figure 1a. The F4 time series is shown as a blue trace
(with left palm in white).
Additional file 5: Animation tracing change in position in PC1, PC2
and PC3 with time for all body sites across both individuals.
Background colors correspond to Figure 1a. The M3 time series is shown
as a red trace (with left palm in orange), and the F4 time series is shown
as a blue trace (with left palm in white).
Additional file 6: Animation tracing change in position in PC1, PC2
and PC3 with time for all body sites across M3. Background colors
correspond to Figure 1a. The M3 time series is shown as a red trace
(with left palm in orange).
Additional file 7: Animation tracing change in position in PC1, PC2
and PC3 with time for all body sites across F4. Background colors
correspond to Figure 1a. The F4 time series is shown as a blue trace
(with left palm in white).
Additional file 8: Temporal variation in phylum, class, order, family,
and genus abundances (M3 gut). The x-axis scale differs between M3
and F4 plots.
Additional file 9: Temporal variation in phylum, class, order, family,
and genus abundances (F4 gut). The x-axis scale differs between M3
and F4 plots.
Additional file 10: Temporal variation in phylum, class, order,
family, and genus abundances (M3 tongue). The x-axis scale differs
between M3 and F4 plots.
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Additional file 11: Temporal variation in phylum, class, order,
family, and genus abundances (F4 tongue). The x-axis scale differs
between M3 and F4 plots.
Additional file 12: Temporal variation in phylum, class, order,
family, and genus abundances (M3 left palm). The x-axis scale differs
between M3 and F4 plots.
Additional file 13: Temporal variation in phylum, class, order,
family, and genus abundances (F4 left palm). The x-axis scale differs
between M3 and F4 plots.
Additional file 14: Temporal variation in phylum, class, order,
family, and genus abundances (M3 right palm). The x-axis scale
differs between M3 and F4 plots.
Additional file 15: Temporal variation in phylum, class, order,
family, and genus abundances (F4 right palm). The x-axis scale differs
between M3 and F4 plots.
Additional file 16: Taxonomic summary of the persistent and
transient OTUs for all individual, body site pairs.
Additional file 17: Detailed results of persistent versus transient
community compositions when compared on 454 time series and
jackknife analysis.
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Quantitative Insights Into Microbial Ecology; SD: standard deviation; V2:
variable region 2; V4: variable region 4.
Acknowledgements
We wish to acknowledge funding from NIH (HG004872, DK078669, AI070921
and AI083264), ARRA supplement (HG004872-02S1); Crohn’s and Colitis
Foundation of America; the Bill and Melinda Gates Foundation; Amazon
Web Services (AWS) in Education Researchers Grant; and the Howard
Hughes Medical Institute. We additionally wish to acknowledge Nigel Cook
for assisting with deployment of QIIME on AWS, and Reece Gesumaria for
performing DNA extraction.
Author details
Department of Chemistry and Biochemistry, University of Colorado, 215
UCB, Boulder, CO 80309, USA. 2Cooperative Institute for Research in
Environmental Sciences, University of Colorado, 216 UCB, Boulder, CO 80309,
USA. 3Department of Microbiology and Immunology, Stanford University
School of Medicine, 299 Campus Drive, Stanford, CA 94305, USA.
4
Department of Computer Science, University of Colorado, 430 UCB, Boulder,
CO 80309, USA. 5Institute for Genome Sciences, University of Maryland
School of Medicine, 801 W. Baltimore Street, Baltimore, MD 21201, USA.
6
Department of Ecology and Evolutionary Biology, University of Colorado,
UCB 334, Boulder, CO 80309, USA. 7Center for Genome Sciences and
Systems Biology, Washington University School of Medicine, 4444 Forest Park
Blvd, St Louis, MO 63108, USA. 8Howard Hughes Medical Institute, University
of Colorado, 215 UCB, Boulder, CO 80309, USA.
1

Authors’ contributions
JGC performed data analysis and wrote the manuscript; CLL assisted with
study design, sample preparation and sequencing, and provided feedback
on the manuscript; EKC assisted with study design and sample collection,
and provided feedback on the manuscript; DB assisted with sample
preparation and sequencing, and provided feedback on the manuscript; AG
and JS assisted with data analysis; DK assisted with data analysis and
provided feedback on the manuscript; PG and JR provided assistance with
generation of InVUE animated plots; NF and JIG conceived of the study and
provided feedback on the manuscript; and RK conceived of the study and
wrote the manuscript. All authors have read and approved the manuscript.
Received: 7 March 2011 Revised: 8 May 2011 Accepted: 30 May 2011
Published: 30 May 2011

Page 7 of 8

References
1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M,
Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial
flora. Science 2005, 308:1635-1638.
2. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R,
Angenent LT, Ley RE: Succession of microbial consortia in the developing
infant gut microbiome. Proc Natl Acad Sci USA 2011, 108(Suppl
1):4578-4585.
3. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO: Development of the
human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
4. Dethlefsen L, Huse S, Sogin ML, Relman DA: The pervasive effects of an
antibiotic on the human gut microbiota, as revealed by deep 16S rRNA
sequencing. PLoS Biol 2008, 6:e280.
5. Dethlefsen L, Relman DA: Incomplete recovery and individualized
responses of the human distal gut microbiota to repeated antibiotic
perturbation. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4554-4561.
6. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R: Bacterial
community variation in human body habitats across space and time.
Science 2009, 326:1694-1697.
7. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI: The effect
of diet on the human gut microbiome: a metagenomic analysis in
humanized gnotobiotic mice. Sci Transl Med 2009, 1:6ra14.
8. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE,
Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC,
Knight R, Gordon JI: A core gut microbiome in obese and lean twins.
Nature 2009, 457:480-484.
9. Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H,
Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van
Sinderen D, O’Connor M, Harnedy N, O’Connor K, Henry C, O’Mahony D,
Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O’Toole PW:
Composition, variability, and temporal stability of the intestinal
microbiota of the elderly. Proc Natl Acad Sci USA 2010, 108(Suppl
1):4586-4591.
10. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S,
Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L,
Forney LJ: Vaginal microbiome of reproductive-age women. Proc Natl
Acad Sci USA 2011, 108(Suppl 1):4680-4687.
11. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P,
Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C,
Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD,
Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R,
Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J,
et al: The NIH Human Microbiome Project. Genome Res 2009,
19:2317-2323.
12. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T,
Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J,
Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM,
Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, et al:
A human gut microbial gene catalogue established by metagenomic
sequencing. Nature 2010, 464:59-65.
13. Fierer N, Hamady M, Lauber CL, Knight R: The influence of sex,
handedness, and washing on the diversity of hand surface bacteria. Proc
Natl Acad Sci USA 2008, 105:17994-17999.
14. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA,
Turnbaugh PJ, Fierer N, Knight R: Global patterns of 16S rRNA diversity at
a depth of millions of sequences per sample. Proc Natl Acad Sci USA
2011, 108(Suppl 1):4516-4522.
15. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK:
Analysis of the fecal microflora of human subjects consuming a
probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ
Microbiol 2000, 66:2578-2588.
16. Scanlan PD, Shanahan F, O’Mahony C, Marchesi JR: Culture-independent
analyses of temporal variation of the dominant fecal microbiota and
targeted bacterial subgroups in Crohn’s disease. J Clin Microbiol 2006,
44:3980-3988.
17. Martinez I, Kim J, Duffy PR, Schlegel VL, Walter J: Resistant starches types 2
and 4 have differential effects on the composition of the fecal
microbiota in human subjects. PLoS One 2010, 5:e15046.
18. Hamady M, Lozupone C, Knight R: Fast UniFrac: facilitating highthroughput phylogenetic analyses of microbial communities including
analysis of pyrosequencing and PhyloChip data. ISME J 2009, 4:17-27.

Caporaso et al. Genome Biology 2011, 12:R50
http://genomebiology.com/2011/12/5/R50

Page 8 of 8

19. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T,
Dalevi D, Hu P, Andersen GL: Greengenes, a chimera-checked 16S rRNA
gene database and workbench compatible with ARB. Appl Environ
Microbiol 2006, 72:5069-5072.
20. Edgar RC: Search and clustering orders of magnitude faster than BLAST.
Bioinformatics 2010, 26:2460-2461.
21. Knights D, Kuczynski J, Koren O, Ley RE, Field D, Knight R, Desantis TZ,
Kelley ST: Supervised classification of microbiota mitigates mislabeling
errors. ISME J 2010, 5:570-573.
22. inVUE.. [http://sourceforge.net/apps/mediawiki/invue/].
doi:10.1186/gb-2011-12-5-r50
Cite this article as: Caporaso et al.: Moving pictures of the human
microbiome. Genome Biology 2011 12:R50.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

